Understanding the patient experience of chronic kidney disease stages 2–3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief

Abstract

Background Qualitative patient interviews and patient-reported outcome instruments are important tools to understand the patient experience of disease. The aim of this study was to use patient interviews to identify concepts relevant and important to patients living with chronic kidney disease (CKD) stages 2–3b, develop a comprehensive conceptual model of the patient experience and debrief the Kidney Disease Quality of Life 36-item instrument (KDQOL-36) for patients with CKD stages 2–3b. Methods Concept elicitation interviews were conducted with patients with CKD stages 2–3b to identify signs/symptoms and impacts most relevant and important to patients (i.e., ‘salient’ concepts) and develop a conceptual model for the disease. Based on the salient concepts identified in the interviews, new items were proposed to supplement the KDQOL-36. Cognitive debriefing was performed to evaluate the KDQOL-36 and the additional items. Results A total of 31 patients were interviewed in this study (22 for concept elicitation and 15 for cognitive debriefing). The interviews identified 56 concepts (33 signs/symptoms and 23 impacts), 17 of which had not been identified in a previous literature review. Four signs/symptoms (‘fatigue/lack of energy/tiredness’, ‘sleep problems’, ‘increased urination [including nocturia]’ and ‘swelling in legs/ankles/feet’) and two impacts (‘anxiety/worry’ and ‘general negative emotional/mental impact’) were identified as salient. Of the salient signs/symptoms, three were not covered by the KDQOL-36 (sleep problems, increased urination and swelling in legs/ankles/feet) and were represented during cognitive debriefing interviews through four additional items (trouble falling asleep, trouble staying asleep, increased urination [including nocturia] and swelling in legs/ankles/feet) generated in the style of the KDQOL-36. All patients found the KDQOL-36 plus the four additional items relevant, and the majority found them clear. Conclusions By identifying previously unknown concepts and augmenting the understanding of which are most important to patients, a comprehensive conceptual model was developed for patients who have CKD stages 2–3b. This study also demonstrates the suitability of the KDQOL-36 for patients who have CKD stages 2–3b and provides suggestions for how the instrument could be further developed to more comprehensively capture patient experience.

Healthcare utilization, quality of life, and work productivity associated with primary hyperoxaluria: a cross-sectional web-based US survey

“…HRQOL was assessed by administering the Kidney Disease Quality of Life (KDQOL-36™) [25][26][27] and Wisconsin Stone Quality of Life (WISQOL) [28,29] questionnaires, both of which are kidney disease-specific, multidimensional, and psychometrically validated.…”

“…The KDQOL-36 is the most widely used survey in patients on dialysis but is also suitable for patients with less severe chronic kidney disease [25][26][27]30]. It comprises five subscales as follows: Physical Component Summary (PCS), Mental Component Summary (MCS), Burden of Kidney Disease (BKD), Symptoms and Problems of Kidney Disease (SPKD), and Effects of Kidney Disease (EKD).…”

Quality of life of patients with pre-dialysis chronic kidney disease, its relationship with oxidant stress and uromodulin excretion

“…Щорічно майже 5 % смертей пов'язані з порушенням функції нирок. На сьогодні ХХН є глобальним тягарем для охорони здоров'я, прогресування ХХН до 5-ї стадії пов'язане зі суттєвим збільшенням витрат (у 1,3-4,2 раза), і витрати на одного пацієнта на рік становлять 20 000-100 000 доларів США [1][2][3][4][5][6][7][8][9].…”

“…Vol. 12, No 1,. 2023 Оригінальні статті / Original Articles Було оцінено наступні параметри, що є релевантними маркерами прогресування ХХН: рШКФ, САТ, ДАТ, САК.…”

Association of nocturia with estimated glomerular filtration rate: a cross-sectional study from the NHANES 2005-2018

“…Importantly, moderate and severe symptoms of the lower urinary tract are possible mortality risk factors [9]. A review on the Kidney Disease Quality of Life (KDQOL-36) identi es increased urination (including nocturia) as a prominent symptom in patients with chronic kidney disease stages 2-3b [10]. Nocturia may be in uenced by renal function, diurnal changes in arginine vasopressin (AVP) production, sex, and old age [11].…”